WADA study shows no meaningful link between TUE’s and winning an Olympic medal


WADA study shows no meaningful link between TUE’s and winning an Olympic medal

According to a study undertaken by the World Anti-Doping Agency (WADA) there is no meaningful link between an athlete having a Therapeutic Use Exemption (TUE) and winning an Olympic medal.

The study was undertaken by WADA Medical Director, Dr Alan Vernec, and WADA TUE Manager, David Healy, who studies the five summer and winter Olympics that occurred during the period of 2010 to 2018. The study aimed to determine whether or not those with TUE’s won more medals than those athletes without a TUE.

A TUE allows athletes to use an otherwise prohibited substance in order to treat a legitimate medical condition and must be granted by an anti-doping organisation before use in competition. Dr Vernec said that “The data showed that the number of athletes competing with valid TUEs at the selected Games was less than 1%. Furthermore, the analysis suggests that there is no meaningful association between competing with a TUE and the likelihood of winning a medal.”

Many factors were taken into account during the study such as countries having greater resources meaning that athletes would have better access to superior training facilities, medical and coaching. Overall, the study found that 2062 medals were awarded throughout the five studied Olympics with only 21 of these medals being won by athletes with a TUE.

You can access the full study here.

You may also like

View All

Sport Resolutions Annual Conference 2025 in association with Winston & Strawn LLP is now Sold Out

We’re excited to share that the Sport Resolutions Annual Conference 2025 has reached full capacity!

Read More

The Governance of Football – is it broken and does it need fixing?

SESSION ANNOUNCEMENT | Sport Resolutions Annual Conference 2025 in association with Winston & Strawn LLP

Read More

The Supreme Court ruling and its impact on sport

SESSION ANNOUNCEMENT | Sport Resolutions Annual Conference 2025 in association with Winston & Strawn LLP

Read More

Newsletter Signup

Please enter your email address below: